Diabetes Care Devices - Sweden

  • Sweden
  • In Sweden, revenue in the Diabetes Care Devices market market is projected to reach US$173.50m in 2024.
  • This revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 12.27%.
  • Consequently, the market volume is anticipated to reach US$309.50m by 2029.
  • In a global context, the highest revenue will be generated the United States, with a projection of US$11,710.00m in 2024.
  • Sweden is witnessing a growing demand for innovative diabetes care devices, driven by the increasing prevalence of diabetes and a strong emphasis on patient-centered healthcare solutions.

Key regions: Netherlands, Japan, France, Italy, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diabetes Care Devices Market in Sweden is experiencing considerable growth, fueled by factors such as technological advancements, increased prevalence of diabetes, and heightened awareness of diabetes management among the population, enhancing patient care and outcomes.

Customer preferences:
In Sweden, there is a noticeable shift towards personalized diabetes care solutions, as patients increasingly prefer devices that offer tailored insights and real-time data. The rise of smart insulin pens and continuous glucose monitoring systems reflects a growing desire for user-friendly, connected devices that integrate seamlessly into daily life. Additionally, the cultural emphasis on holistic health and sustainability is influencing consumer choices, driving interest in eco-friendly products and applications that promote healthy living alongside diabetes management.

Trends in the market:
In Sweden, the Diabetes Care Devices Market is experiencing a surge in demand for advanced digital health solutions that prioritize personalization and connectivity. Continuous glucose monitoring (CGM) systems are becoming increasingly popular, enabling patients to track their glucose levels in real-time and receive tailored insights. Smart insulin pens are also gaining traction, providing precise dosing and data integration with mobile applications. This trend reflects a broader cultural shift towards holistic health management and sustainability, prompting industry stakeholders to innovate eco-friendly products and enhance user experience, while addressing the evolving needs of diabetes patients.

Local special circumstances:
In Sweden, the Diabetes Care Devices Market is shaped by a robust healthcare system that emphasizes patient-centric care and digital innovation. The country's high level of smartphone usage and strong internet connectivity facilitate the adoption of advanced diabetes management tools, such as mobile apps and remote monitoring systems. Additionally, Sweden's commitment to sustainability drives demand for eco-friendly medical devices. Regulatory support further enhances market dynamics, with stringent quality standards ensuring the reliability of diabetes care devices, fostering trust among consumers and healthcare providers alike.

Underlying macroeconomic factors:
The Diabetes Care Devices Market in Sweden is significantly influenced by macroeconomic factors, including the country's strong economic stability and high GDP per capita, which enable substantial healthcare spending. Ongoing investments in healthcare infrastructure and innovation foster the development and adoption of advanced diabetes management technologies. Furthermore, Sweden's proactive fiscal policies support research and development in medical technology, enhancing market dynamics. Global trends, such as the rising prevalence of diabetes and the push for personalized medicine, also contribute to market growth, as do consumer expectations for integrated and user-friendly diabetes care solutions.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)